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Abstract 
Accurately diagnosing autism spectrum disorders (ASD) in adulthood can be challenging. 
Structured questionnaires (SQs) and diagnostic measures (DMs) are frequently used to assist 
case recognition and diagnosis. This study reviewed research evidence on SQs and DMs 
published since the National Institute for Health and Care Excellence evidence update (NICE; 
2014). The Cochrane library, Medline, Embase and PsycINFO were searched. Twenty studies 
met inclusion criteria. Sensitivity and specificity of SQs was best for individuals with 
previously confirmed ASD diagnoses, and reduced in participants referred for diagnostic 
assessments, with discrimination of ASD from mental health conditions especially limited. 
For adults with intellectual disability diagnostic accuracy increased when a combination of 
SQs were used. Evidence suggests some utility of DMs in identifying ASD amongst clinic 
referrals, though specificity for diagnosis was relatively low. In mental health settings the use 
of a single SQ is unlikely to accurately identify adults without ASD, or differentiate ASD 
from mental health conditions. This is important as adults seeking an ASD diagnostic 
assessment are likely to have co-existing mental health conditions. Robust ASD assessment 
tools specifically for use in adult diagnostic health services in the presence of co-occurring 
mental health and neurodevelopmental disorders is a research priority. 
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published since the National Institute for Health and Care Excellence evidence update (NICE; 8 
2014). The Cochrane library, Medline, Embase and PsycINFO were searched. Twenty studies 9 
met inclusion criteria. Sensitivity and specificity of SQs was best for individuals with 10 
previously confirmed ASD diagnoses, and reduced in participants referred for diagnostic 11 
assessments, with discrimination of ASD from mental health conditions especially limited. 12 
For adults with intellectual disability diagnostic accuracy increased when a combination of 13 
SQs were used. Evidence suggests some utility of DMs in identifying ASD amongst clinic 14 
referrals, though specificity for diagnosis was relatively low. In mental health settings the use 15 
of a single SQ is unlikely to accurately identify adults without ASD, or differentiate ASD 16 
from mental health conditions. This is important as adults seeking an ASD diagnostic 17 
assessment are likely to have co-existing mental health conditions. Robust ASD assessment 18 
tools specifically for use in adult diagnostic health services in the presence of co-occurring 19 
mental health and neurodevelopmental disorders is a research priority. 20 
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2 
 
Introduction 23 
The importance of evaluating ASD diagnostic tools in adult populations  24 
Research on the diagnosis of Autism Spectrum Disorder (ASD) has to date predominately 25 
focussed on childhood. Compared to the number of studies recruiting child populations, there 26 
are few studies (e.g. Lehnhardt et al., 2013; Brugha et al., 2015) specifically examining the 27 
psychometric properties of tools used in the diagnosis of suspected ASD in adulthood, for 28 
example the DISCO (Diagnostic Interview for Social and Communication Disorders; Wing et 29 
al., 2002). The tools used in the diagnosis of ASD are structured questionnaires (SQs) that are 30 
generally self-report or informant completed brief measures developed as ASD screening 31 
tools; and diagnostic measures (DMs), which are more in depth assessment tools that tend to 32 
involve semi-structured interviews and interactive tasks to inform an ASD diagnosis 33 
(National Institute for Health and Care Excellence (NICE) 2012; Scottish Intercollegiate 34 
Guidelines Network (SIGN) 2016). For adults with a suspected ASD diagnosis there are 35 
significant limitations in access to high quality diagnostic assessments. The reasons for this 36 
include both the availability of diagnostic services and psychometrically established measures 37 
(Lehnhardt et al., 2013; Powell & Acker, 2016; Brugha et al., 2015). SQs and DMs can assist 38 
clinicians making a diagnosis (NICE, 2012; SIGN, 2016) and can be used in conjunction with 39 
direct observation and other sources of information (ICD-10; APA, 2013). However 40 
childhood measures are not always suitable for adults where the presentation of ASD may be 41 
masked by maturation, learned compensatory skills and the presence of co-occurring mental 42 
health and neurodevelopmental disorders. Further, informants (particularly parents) and 43 
information about early history may be unavailable (Brugha et al., 2012; 2015).  44 
 45 
 46 
 47 
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The NICE (2014) guidelines on case recognition and diagnosis of ASD in adults 48 
As part of the development of evidence-based clinical guidelines for the assessment and 49 
management of ASD in adults, the UK National Institute for Health and Care Excellence 50 
(NICE 2014) reviewed and published evidence on the use of SQs and DMs for case 51 
recognition and diagnosis in adults with suspected ASD. These guidelines recommended a 52 
battery of SQs and DMs that could contribute to an ASD diagnosis (see Table 1 for a 53 
summary).  54 
In practice, clinicians and researchers use a range of SQs and DMs to aid diagnosis, 55 
not all of which were included in the NICE recommendations (Rogers et al., 2015; 56 
Rutherford et al., 2016). For example, when the NICE review (2014) was completed no 57 
diagnostic test accuracy studies were included regarding the use of the Diagnostic Interview 58 
for Social and Communication Disorders (DISCO) (Leekam et al., 2002; Wing et al., 2002) 59 
or the Developmental, Dimensional and Diagnostic Interview (3DI) (Skuse et al., 2004), in 60 
adult populations. In addition, some published SQs (usually in self-report format) have been 61 
developed to measure ASD traits that may not directly map onto diagnostic criteria, e.g. the 62 
AQ (Autism Spectrum Quotient; Baron-Cohen et al., 2001). Given the current availability of 63 
various different tools, the psychometric properties of the SQs and DMs used in clinical and 64 
research practice require further consideration (Rogers et al., 2015; Rutherford et al., 2016).  65 
Aims of the study    66 
  The aims of this systematic review were therefore to: 67 
(a) Identify studies published since the NICE (2014) guidelines update on evidence for the 68 
assessment of ASD in adults that describe the psychometric properties of the SQs and 69 
DMs available to clinicians and researchers for identifying ASD in adults. 70 
(b) Examine the quality of the identified studies. 71 
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(c) Make recommendations about which of the measures, if any, might be most appropriate 72 
for the diagnostic assessment of ASD in adults, based on current evidence. 73 
Table 1 around here 74 
 75 
Method 76 
NICE first published the adult autism clinical guideline (CG142) in 2012 (with an evidence 77 
update in 2014). This systematic literature review includes papers published between January 78 
2013 and October 2017; and coincides with the publication of DSM-5 and the revised criteria 79 
for ASD that are used throughout this paper (APA, 2013). The review search terms and 80 
inclusion criteria are shown in Table 2. 81 
Titles and abstracts were screened by SW with 20% screened independently by a 82 
second reviewer (TB). SW and TB reviewed full texts of selected articles independently; 83 
uncertainties about inclusion were resolved through discussion with the research team. The 84 
selection process to determine eligibility of articles for inclusion in the review is shown in 85 
Figure. 1. Data were synthesised narratively and risk of bias was assessed using the 86 
QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies) measure for examining 87 
the quality of diagnostic studies (Whiting et al., 2011; Campbell et al., 2015). The second 88 
reviewer independently rated 20%; reviewers 1 and 2 had 96% agreement on bias ratings.  89 
Table 2 around here 90 
 91 
Results 92 
3887 articles were identified after removal of duplicates (Figure 1). 83 articles were read in 93 
full and twenty articles were selected for inclusion in the review. A brief summary of the 94 
characteristics of the measures from the selected articles is provided in Table 3. 95 
Figure 1 around here 96 
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Bias ratings are shown online in the data supplement Table (DS1) and summarized with the 97 
current review’s findings for each measure. Most studies were conducted in Europe, two in 98 
Japan (Nishiyama et al., 2014; Takei et al., 2014) and four in the USA (Hus and Lord, 2014; 99 
Grodberg et al., 2014; Pugliese et al., 2015; Maddox et al., 2017). Two studies were multi-100 
site with participants recruited from the USA, UK and Germany (Derks et al., 2017; Sappok 101 
et al., 2017). Six studies focussed on adults with intellectual disabilities (Sappok et al., 2014, 102 
2015a, 2017; Mutsaerts et al., 2016; Derks et al 2017; Heinrich et al., 2017). Study designs 103 
were case-control, cross sectional or retrospective.   104 
 105 
Table 3 around here 106 
 107 
Structured questionnaires 108 
SQs are usually self-report (but can be informant completed), do not require training for 109 
administration and have been used in epidemiological studies, and to gather information prior 110 
to a full diagnostic assessment (NICE 2014; Mutsaerts et al., 2016). Evidence for SQs 111 
available at the time of the NICE (2014) recommendations is shown in Table 1; new evidence 112 
identified in the current review from studies evaluating SQs since the NICE (2014) guideline 113 
is shown in Table 4. 114 
 115 
Autism Spectrum Quotient (AQ) (Baron-Cohen et al., 2001) 116 
The evidence for the psychometric properties of the AQ published since the NICE (2014) 117 
guidelines and covered in the current review is not consistent, varying according to study 118 
design and recruitment source. The sensitivity and specificity of the AQ-50 and the AQ-10 119 
was good (≥80%) when comparing archival clinical data from adults with ASD, against a 120 
general population group (Booth et al., 2013). However this is not equivalent to the 121 
6 
 
population of subjects presenting to ASD diagnostic assessment settings. In such settings case 122 
recognition and the need to consider both differential diagnosis and the identification of 123 
additional mental health problems can be challenging.  124 
In a Japanese study (Nishiyama et al., 2014) recruiting individuals with a known 125 
diagnosis of ASD, and a comparison general population sample, the internal consistency and 126 
construct validity of short versions of the AQ were inconsistent. A strength of the study was 127 
that a battery of screening measures were administered to all participants, including the 128 
general population comparator group, to identify any co-occurring mental health conditions.  129 
A further study recruiting individuals with schizophrenia (Lugnegard et al., 2015) 130 
from a psychiatric clinic, adults with ASD and individuals from the general population, found 131 
that ASD and schizophrenia were both significantly associated with a higher AQ-50 score. In 132 
addition, only the AQ version with a binary response option discriminated reliably between 133 
ASD and schizophrenia and only on one subscale (attention switching) (Lugnegard et al., 134 
2015). There was no significant difference in AQ-50 scores between individuals with ASD 135 
and those with schizophrenia when using the 4-point response option. Participants were 136 
diagnosed prior to the study, though diagnoses of ASD and schizophrenia were confirmed in 137 
this study using the DISCO-11 (Wing et al 2002) and the Structured Clinical Interview for 138 
DSM-IV diagnosis (SCID-1; First & Gibbon 2004) respectively. However, such purposive 139 
recruitment of individuals with a defined specific diagnosis is not comparable to the use of 140 
the AQ in ASD diagnostic assessment clinical settings.   141 
In the fourth paper (Sizoo et al., 2015), individuals attending an ASD diagnostic clinic 142 
completed abbreviated versions of the AQ prior to a clinical assessment. The comparison 143 
group again consisted of individuals from the general population. Reported specificity (over 144 
66%) and sensitivity (57-62%) was lower than in the Booth et al (2013) study. A strength of 145 
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the study was the recruitment of participants from ASD clinics and administration of the AQ 146 
prior to their full assessment, which is similar to procedures in clinical settings.  147 
Finally, Ashwood et al., (2016) reported findings using the subject and informant 148 
versions of the AQ-50 and the AQ-10. Participants were consecutively referred to an ASD 149 
assessment clinic, and had high rates of comorbid mental health conditions. Across both AQ 150 
versions sensitivity was above 71% but specificity was less than 38%, and the relationship 151 
between the AQ scores and the ADI-R and the ADOS-G was weak. Thus the AQ did not 152 
reliably identify those individuals who did not have ASD. The presence of mental health 153 
conditions (such as a generalised anxiety disorder) also increased the risk of false positive 154 
ASD diagnoses using the AQ10 (Ashwood et al., 2016). This study highlights the limitations 155 
of the AQ in a more ecologically valid setting compared to studies using non-clinical general 156 
population comparison groups.  157 
Thus overall, the findings from these studies suggest that due to low levels of 158 
specificity the AQ is not a reliable indicator of which people should progress to a full ASD 159 
assessment. 160 
 161 
Ritvo Autism Asperger Diagnostic Scale-Revised (RAADS-R) (Ritvo et al., 2011)  162 
When the RAADS-R was used in an ASD assessment service (Sizoo et al., 2015) and 163 
compared to a general population group, sensitivity was good (73%) but specificity was low 164 
(58%). This indicated some problems accurately identifying those without ASD (Sizoo et al., 165 
2015). Limitations in this study are similar to those reporting on the AQ, including the use of 166 
a case-control design, and purposive recruitment of a general population comparison group 167 
that lacked mental health or developmental assessment. A study strength was that participants 168 
were recruited from ASD assessment services and administered the RAADS-R prior to full 169 
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ASD assessment. The low levels of specificity reported suggest the RAADS-R was not a 170 
reliable indicator of those who should progress to a full ASD assessment. 171 
The psychometric properties of a 14-item version (the RAADS-14) were tested by 172 
Eriksson et al. (2013) in an ASD group, a clinical control group (individuals with ADHD, 173 
mood, psychotic and borderline personality disorders), and a general population group. The 174 
ASD group had significantly higher scores compared with the clinical control group. 175 
However, although both sensitivity (97%) and specificity (95%) was good with general 176 
population controls, the specificity for comparison with the clinical control group was 177 
reduced (to 46% with ADHD) (Eriksson et al., 2013). Comparison to a psychiatric control 178 
group was clinically relevant, but study limitations again included case-control design, and 179 
the lack of a consistent use of ASD and/or other mental health assessments in the control 180 
group; in addition some participants were recruited online and for these individuals diagnoses 181 
were self-reported and not confirmed.          182 
 183 
Social Responsiveness Scale 2 (SRS-2) (Constantino & Gruber, 2005) 184 
Full and shortened versions of the adult self-report SRS-2 were translated into Japanese 185 
(Nishiyama et al., 2014) and completed by individuals recruited from the general population 186 
and from clinical services. These versions had good internal consistency but were correlated 187 
with symptoms of psychoticism and distress as measured by the Brief Symptom Inventory 188 
(BSI) (Derogatis & Melisaratos 1983) and the K10 (Kessler et al., 2002). A strength of the 189 
study was that the general population group were administered a battery of mental health 190 
screening measures; a limitation was diagnosis of participants prior to the study. 191 
A Japanese translation of the SRS informant version (Takei et al., 2014) demonstrated 192 
good sensitivity in both genders, and good specificity in men with ASD, compared to 193 
individuals in a control group with mental health difficulties. However, specificity in women 194 
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was reduced (61%) indicating limitations in identifying women who did not have ASD 195 
(Takei et al., 2014). A strength of this study was confirmation of diagnosis by the research 196 
team; a limitation was that only individuals in the ASD group completed a reference standard 197 
(the ADOS), the control group had no clinical assessment to exclude the presence of ASD.  198 
 199 
Social Communication Questionnaire (SCQ) (Berument et al., 1999) 200 
The SCQ (German version) was completed by parents or professional carers (in the majority 201 
of cases), of adults with intellectual disability and suspected ASD as part of routine clinical 202 
assessments of consecutive admissions to an intellectual disability mental health service 203 
(Sappok et al., 2015a). Interestingly, the SCQ current version (assesses the last 3 months) was 204 
found to be more effective than the lifetime version; the best combination of sensitivity 205 
(89%) and specificity (66%) was achieved by raising the SCQ cut-score for ASD from 15 to 206 
18. When the focus was on lifetime development, specificity decreased to 48%. This finding 207 
may have been because the SCQ was completed by a professional carer who may not have 208 
known about a subject’s early development, rather than a family member. 87% of included 209 
participants had a moderate/severe intellectual disability, so the findings may not generalise 210 
to adults with milder intellectual disability (Sappok et al., 2015a). A strength of the study was 211 
that no exclusions were made on grounds of neurodevelopmental or mental health 212 
comorbidities, increasing the clinical validity of the sample.  213 
Cross-cultural validity of the SCQ current version was examined in a study recruiting 214 
adults with intellectual disability from mental health services in Germany, the UK and the 215 
USA (Sappok et al., 2017). In contrast to the previous study (Sappok et al., 2015a) a lower 216 
cut-score of 13 was found optimal and made for sensitivity of 87% and specificity of 58%. 217 
More severe levels of intellectual disability were associated with higher scores. In some cases 218 
administration of the SCQ was prior to an ASD assessment so informants completing the 219 
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measure were blind to diagnosis; however variations in administration of the SCQ in different 220 
countries may have introduced bias. SCQ scores were influenced by gender and country with 221 
males and those recruited in Germany having higher scores.   222 
 223 
Structured questionnaires developed for use with adults with intellectual disability 224 
Social Communication Questionnaire for Adults with Intellectual Disabilities (SCQ-AID) 225 
(Derks et al., 2017) 226 
International data (from Germany, the USA and UK) were collected from individuals 227 
recruited via intellectual disability mental health settings with the SCQ-AID completed by 228 
carers or researchers. The new algorithm with a cut-point of 9 demonstrated sensitivity of 229 
81% suggesting the shortened version has clinical utility though as found by Sappok et al., 230 
(2015a, who used the original version) specificity was low (62%). A strength of the study 231 
was the international recruitment of participants; however the authors noted some differences 232 
in diagnostic process across sites. Further independent evaluation of this new measure is 233 
needed. 234 
 235 
The Diagnostic Behavioural Assessment for ASD – Revised (DiBAS-R) (Sappok et al., 2015b) 236 
When the DiBAS-R was completed by a relative or staff member supporting an adult 237 
accessing an intellectual disability service, rates of 81% sensitivity and specificity were found 238 
when comparing those with and without ASD (Sappok et al., 2014). These findings using this 239 
new measure are encouraging, and a strength of the study is that diagnoses were made 240 
contemporaneously therefore replicating circumstances from clinical settings. Further 241 
evaluation in other populations of adults with intellectual disability is required.  242 
In a study of consecutive referrals to a specialist intellectual disability psychiatric 243 
clinic in Germany, DiBAS-R sensitivity was 82% and specificity 67%. Diagnostic accuracy 244 
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was better in adults with mild/moderate intellectual disability than those with severe 245 
intellectual disability (for whom specificity dropped to 34%) (Heinrich et al., 2017). A 246 
strength of the study was that the DiBAS-R was completed by carers, prior to a full 247 
diagnostic assessment, and was therefore representative of the clinical process.  248 
One study used a combination of the DiBAS-R and the Autism Checklist (ACL) and is 249 
described below (Mutsaerts et al., 2016).  250 
 251 
Autism Checklist (ACL) (Sipes and Matson, 2014) 252 
In a psychiatric clinic for adults with intellectual disability, Mutsaerts et al., (2016) reported 253 
that combined use of the ACL and the DiBAS-R led to improved sensitivity of 95% (when 254 
there was a positive screen on at least one measure) compared to when each measure was 255 
used alone (91%/75% respectively). Combined use also led to an increase in specificity to 256 
88% (when there were positive screens on both measures) compared to using each measure 257 
separately (75%) (Mutsaerts et al., 2016). The inclusion of data collected from people 258 
referred to clinic was a study strength.  259 
Table 4 around here 260 
 261 
Diagnostic measures and observational assessments  262 
Findings from studies of DMs and observational assessments, are shown in Table 5. 263 
 264 
Diagnostic measures: interviews 265 
Autism Diagnostic Interview-Revised (ADI-R) (Lord et al 1994) 266 
The ADI-R was evaluated with adults without intellectual disability who were consecutively 267 
referred (mostly by self or a relative) to an ASD diagnosis clinic in Italy (Fusar-Poli et al., 268 
2017). Overall the ADI-R had low sensitivity (43%) but good specificity (95%). In contrast 269 
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across the subscale domains sensitivity was acceptable (over 60%) and specificity was good 270 
(over 79%), with the exception of the restricted, repetitive and stereotyped behaviours 271 
domain (just 37%). 272 
When the ADI-R and ADOS-G were combined sensitivity was still low (42%). The 273 
authors noted that the ADI-R may work less well with higher-functioning adults because a 274 
significant number of items rely on developmental history, and so more subtle presentations 275 
later in life may be missed (Fusar-Poli et al., 2017). It was a strength of the study that those 276 
administering the ADI-R were blind to DSM-5 based clinical consensus and that a third of 277 
participants already had a psychiatric diagnosis.       278 
 279 
Diagnostic measures: observational 280 
Autism Diagnostic Observation Schedule (second edition) (ADOS-2) Module 4 revised 281 
algorithm (Lord et al., 1999; Lord et al., 2012)  282 
Hus & Lord (2014) reported sensitivity and specificity of the new revised Module 4 283 
algorithm to be above 80% in a study including previous research participants and individuals 284 
presenting to a developmental disabilities clinic (the control group comprised individuals 285 
with a variety of DSM-IV-TR disorders). The severity scores were mostly independent of 286 
verbal IQ and race. A limitation of the study was the retrospective design, and exclusion of 287 
some individuals with a relative with ASD, so these new algorithms do require replication in 288 
other groups.  289 
In a Dutch study of individuals with ASD and three different control groups de Bildt 290 
et al. (2016) reported a sensitivity of 61% for the ADOS Module 4. However, specificity 291 
varied according to the comparator group: 95-100% for individuals recruited from non-292 
clinical or forensic settings, compared to 22-50% for individuals with schizophrenia (de Bildt 293 
et al., 2016). Items that were endorsed by the ASD group, but not by individuals with 294 
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schizophrenia included ‘quality of rapport’, ‘conversation’, ‘quality of social responses’ and 295 
‘highly specific topics’. Limitations in the study design included the small sample size, and 296 
the use of archival video data with individuals being diagnosed prior to the study.  297 
 In the third study Pugliese et al., (2015) investigated individuals referred for an ASD 298 
assessment and previous research participants (many of whom met criteria for a range of 299 
diagnoses) using the ADOS-2 Module 4, and a cut-point of 8. The study found that while 300 
sensitivity was 85% (80-89% across research sites), specificity was somewhat lower at 72% 301 
(62-91%). The results were best for women and those with above or below average verbal IQ. 302 
Limitations in the study design included variability in the reference standards used to confirm 303 
a diagnosis of ASD, and omission of any description of blinding during administration of the 304 
tests.   305 
Langmann et al., (2017) investigated the performance of the original and revised 306 
ADOS-2 Module 4 algorithms using retrospective data. Participants were adults and 307 
adolescents with suspected ASD who had been referred to specialist ASD diagnostic clinics 308 
in psychiatry services. The revised algorithm demonstrated slightly better performance 309 
overall (sensitivity 86% and specificity 80% at cut point 8) compared to the original 310 
algorithm. However specificity for adults with a diagnosis of personality disorder compared 311 
to ASD was poor (individuals with personality disorder comprised 58% of false positive 312 
cases). In addition diagnostic accuracy was less for women and older individuals. However a 313 
possible limitation to the generalisability of these findings was that less than a quarter of 314 
those recruited were female and only 25% were over age 24 years. 315 
Fusar-Poli et al., (2017) evaluated the ADOS-2 Module 4 with adults whose IQ was 316 
over 70 and who were consecutively referred to an ASD diagnosis clinic in Italy. The 317 
majority of participants were self or relative-referrals. The original ADOS-2 Module 4 318 
algorithm (Lord et al 2012) had sensitivity of over 86% across all domains. Sensitivity of the 319 
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revised algorithm (Hus & Lord 2014) was 87%. Specificity was 83% for the original 320 
algorithm but reduced on individual domains (63%) and was 74% on the revised algorithm. 321 
Strengths of the study included the avoidance of a case-control design, and that those 322 
administering the ADOS-2 were blind to DSM-5 based clinical consensus. In addition, and as 323 
would be expected in a clinical setting, a proportion of those recruited had existing 324 
psychiatric diagnoses (37%).  325 
Maddox et al., (2017) found the original and revised algorithms for the ADOS-2 326 
Module 4 (Lord et al 2012; Hus & Lord 2014) had a sensitivity of 100% while specificity 327 
was 74% and 70% respectively. A strength of the study was recruitment of participants from 328 
psychiatric settings; however study findings indicated a high number of participants with 329 
psychosis falsely met criteria for ASD and that the social-communication domain was 330 
particularly limited in discriminating between the two. 331 
 332 
Short observational assessments 333 
Autism Mental State Examination (AMSE) (Grodberg et al., 2012) 334 
The AMSE was reported to have good sensitivity and specificity for discriminating ASD 335 
from other disorders using the ADOS-G or the ADI-R (Grodberg et al., 2014). Strengths of 336 
the study design included blinded administration of the measure, and the consecutive 337 
recruitment of individuals who self-referred for assessment of ASD.  338 
Table 5 around here 339 
 340 
Discussion 341 
Key Findings 342 
The two key findings of the review are that, overall, there is very limited evidence to support 343 
the use of structured questionnaires (SQs: self-report or informant completed brief measures 344 
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developed to screen for ASD) in the assessment and diagnosis of ASD in adults. Further the 345 
evidence regarding the use of diagnostic measures (DMs: more in depth assessment tools 346 
involving semi-structured interviews and interactive tasks) suggests some utility in 347 
identifying ASD amongst clinic referrals, though specificity for eventual diagnosis of ASD 348 
was still relatively low. For both types of assessment tools, more evidence is required 349 
regarding their use in diagnostic assessments. We consider that tools are useful, but only as 350 
an aid to diagnostic decision making within a broader multidisciplinary team ASD 351 
assessment. These conclusions are in keeping with the NICE (2014) guidelines that suggest 352 
using a battery of tools to support the diagnostic process.  353 
  354 
Structured Questionnaires. The new information reported compliments but does not change 355 
the overall NICE (2014) recommendations regarding SQs. Most SQs show limited utility in 356 
identifying those who did not have ASD (Ashwood et al., 2016). This finding was evident in 357 
studies recruiting participants in clinically realistic settings (e.g. Ashwood et al., 2016) 358 
compared to studies using a case-control design with a general population comparator (e.g. 359 
Booth et al., 2013). There were particular problems differentiating ASD from schizophrenia, 360 
which may be in part a consequence of the potential overlap in symptoms (e.g. flattened 361 
affect and aspects of social-communication) and/or underlying genetic phenotype (Cross-362 
Disorder Group of the Psychiatric Genomics, 2013). Given the low specificity, the AQ and 363 
the RAADS-R should not in our opinion be used on their own for screening and case 364 
recognition in clinical settings. Based on published data this would apply to all versions of 365 
the AQ including the abbreviated 10 item version recommended by NICE (2014). Regarding 366 
the SRS, at the time of the NICE (2014) recommendations there were no diagnostic accuracy 367 
studies that met guideline inclusion criteria. New evidence suggests the accuracy of the SRS 368 
(Japanese translation) for adults may be limited in women, and in the presence of symptoms 369 
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of psychoticism or distress as measured using screening tools (Nishiyama et al., 2014; Takei 370 
et al., 2014). Evidence for the diagnostic accuracy of the SCQ with adults was not available 371 
previously. In the current review the SCQ was found to be more effective when using a 372 
higher cut-off score in a German cohort (Sappok et al., 2015a). However when an 373 
international cohort was recruited (Germany, USA and the UK) a lower cut-score improved 374 
diagnostic accuracy (Sappok et al., 2017). Where professional carers completed the current 375 
SCQ (without reference to developmental history) for adults with intellectual disability in a 376 
clinical setting, this showed better sensitivity and specificity than the lifetime version 377 
(Sappok et al., 2015a). This highlights the potential difficulty of gathering a developmental 378 
history to support the diagnosis of ASD in adults, which has implications for the choice of 379 
diagnostic tools used. A new and shortened version (the SCQ-AID) used in an international 380 
study had good sensitivity but low specificity, however the authors note some variation in 381 
diagnostic rates and processes across countries (Derks et al., 2017). This review found no 382 
new evidence regarding the ASDI or the AAA. 383 
 384 
Diagnostic Measures. Studies assessing the psychometric properties of DMs (such as the 385 
ADOS-2 module 4) reported some success identifying ASD among clinic referrals though 386 
limitations remained. The ADOS-G and ADI were recommended by NICE for use with 387 
adults with and without intellectual disability. New evidence shows the new ADOS-G 388 
algorithms had good sensitivity and specificity in a study with a case-control design (Hus & 389 
Lord 2014). This was to a certain extent replicated (specificity was acceptable) in individuals 390 
consecutively referred to a psychiatric clinic with a variety of diagnoses (Fusar-Poli et al., 391 
2017). However new studies also indicated that in clinical groups, specificity was reduced for 392 
schizophrenia, personality disorder and psychosis (de Bildt et al., 2016; Maddox et al., 2017; 393 
Langmann et al., 2017). Scores were additionally found to interact with gender and IQ 394 
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although further studies are required to replicate these findings before definite conclusions 395 
can be made (Pugliese et al., 2015; Langmann et al., 2017). The ADI-R demonstrated mixed 396 
results in adult ASD clinic referrals, having good specificity but low sensitivity (Fusar-Poli et 397 
al., 2017). The AMSE showed promising evidence as a new measure; further studies in other 398 
settings and by teams independent of the authors are required (Grodberg et al., 2014). 399 
 400 
Combinations of tools. NICE (2014) recommended using a battery of tools to support the 401 
diagnostic process. This was based on evidence from studies using SQs and DMs in isolation, 402 
and at the time the guidelines were published there were no diagnostic accuracy studies 403 
regarding use of tools in combination. In the current review only two studies evaluated the 404 
use of a combination of tools. In adults with ASD and intellectual disability, using the ACL 405 
and the DiBAS-R improved the sensitivity and specificity of these tools (Mutsaerts et al., 406 
2016). For adults without an intellectual disability combining the ADI-R and the ADOS-G 407 
improved specificity but reduced sensitivity (Fusar-Poli et al., 2017). Sensitivity of the 408 
combined measures was lower than to using the ADOS-G alone; the authors suggest the ADI-409 
R may be less sensitive to the more subtle presentation of ASDs diagnosed in adulthood 410 
(Fusar-Poli et al., 2017). This new evidence whereby combined use of these measures 411 
improved diagnostic effectiveness is in accordance with NICE (2014) recommendations 412 
regarding a battery of measures (Mutsaerts et al., 2016). 413 
 414 
Strengths and limitations of the review 415 
A strength of this review is that it includes new evidence about measures for which at the 416 
time of the NICE (2014) review publication there was no or limited evidence available (the 417 
SCQ, DiBAS-R, ACL, SRS, and the AMSE). A further strength was that only studies 418 
reporting sensitivity and specificity, or ROC analysis were included. A limitation was that the 419 
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number of studies and the sample sizes reported were relatively small, and heterogeneity in 420 
the design of studies was considerable. Additionally case-control design was highlighted as a 421 
potential source of bias for the existing evidence on tools when the NICE (2014) guidelines 422 
were published; this design limitation was also present in a number of the studies included in 423 
this review. However, the studies reported here that used more ecologically valid designs (for 424 
example, consecutive clinic referrals) also reported poor psychometric properties of most 425 
measures, particularly around specificity.  426 
 427 
Implications  428 
The diagnosis of ASD during adulthood is likely to pose challenges to clinicians and 429 
researchers as people’s presentation may be more subtle (Brugha et al., 2015; Rogers et al., 430 
2015). The presence of other mental health conditions, which is highly likely in individuals 431 
presenting to a specialist mental health service, challenges the accuracy of case recognition of 432 
ASD, and complicates the ability of clinicians and researchers to identify the core symptoms 433 
of ASD (Underwood et al., 2015). The risk of diagnostic overshadowing (i.e. misattributing 434 
behaviours to an existing diagnosis leading to a failure in identifying other diagnoses) as a 435 
consequence of the presence of associated psychiatric disorders may be increased (Cross-436 
Disorder Group of the Psychiatric Genomics Consortium, 2013; Ford & Crewther, 2014). For 437 
many seeking a diagnostic assessment for suspected ASD in adulthood, the likely scenario 438 
will be an assessment in the context of co-occurring mental health needs, additional 439 
neurodevelopmental difficulties, social/relationship difficulties and/or problems with 440 
employment or education (NICE, 2012; Russell., et al 2016). This review highlights the 441 
limitations of the psychometric properties of existing diagnostic tools (SQs and DMs) to aid 442 
the accuracy of diagnostic practice, in adults particularly in the presence of co-occurring 443 
mental health diagnoses. The use of SQs that do not require a trained assessor may be useful 444 
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particularly in community primary and secondary health care settings (e.g. GPs and mental 445 
health services), to gather information about a possible neurodevelopmental disability (Booth 446 
et al., 2013; Allison et al., 2012). However, as already described, SQs alone should not be 447 
used to exclude further ASD assessment other than if the scores are extremely low (Brugha et 448 
al., 2012). 449 
The studies included highlight that performance of SQs and DMs depend on the 450 
circumstances (countries, cultures and clinical setting) in which they are used and evaluated. 451 
For example, using ASD measures to identify individuals with ASD within the general 452 
population is a very different task to using the same measures in mental health and 453 
intellectual disability services, where ASD prevalence would be expected to be higher 454 
(Brugha et al., 2016). The interpretation of data derived from SQs and DMs including the 455 
values for sensitivity and specificity will be affected by both the prevalence of ASD in 456 
particular populations, and by the presence of coexisting conditions including intellectual 457 
disability and mental health conditions (Leeflang et al., 2009; Campbell et al, 2015). In 458 
addition, deciding how best to interpret the significance of particular SQ and DM scores is 459 
not without problems given the possibility that there may be cultural and/or country 460 
differences in scores (Sappok et al 2015a; 2017) in addition to the existing reported different 461 
clinical and research cut-off scores for many measures (Pugliese et al., 2015). Sappok et al., 462 
(2017) note that variations regarding the SCQ scores across countries may relate to 463 
differences in measure administration practices, ASD reference standards and referral 464 
processes. This has implications for international multi-site studies when researchers should 465 
agree cut-offs in advance (Sappok et al., 2017).  466 
An inclusion criterion for the review was that study participants had completed a SQ 467 
or DM as part of a comprehensive ASD diagnostic assessment. However, in some studies, 468 
participants were diagnosed prior to the study and in others participants were consecutive 469 
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new referrals to a diagnostic clinic. Where participants were diagnosed prior to the study it 470 
was not always clear whether the ASD diagnosis was made in childhood or adulthood. This is 471 
important for several reasons: first, the presentation of adults diagnosed in childhood may be 472 
different to that of people referred for a first diagnosis in adulthood. Second, selecting adults 473 
with an existing diagnosis for studies of SQs and DM rather than adults referred for a 474 
suspected diagnosis may influence the sensitivity and specificity values (Leeflang et al., 475 
2009; Campbell et al., 2015). Therefore the findings from studies in which individuals were 476 
first time referrals for an ASD assessment might arguably have more validity for real life 477 
clinical settings.  478 
 479 
Future research  480 
Further research is needed to investigate the accuracy, efficiency and comparative utility of 481 
all the tools identified in this review. Tools may require modification for use in adult ASD 482 
diagnosis services with individuals with or without intellectual disability whose 483 
neurodevelopmental conditions were not recognised in childhood, and for whom the risk of 484 
additional mental health comorbidities is high. Research should compare the sensitivity and 485 
specificity between tools when appropriately used in the diagnostic pathway with 486 
ecologically valid populations, such as individuals presenting to adult mental health settings. 487 
Only then can the clinical utility of individual SQs and DMs be directly compared. The 488 
strongest tools can then be developed further as needed – and others redeveloped, or 489 
discarded. New tools that have robust psychometric properties and that have been constructed 490 
specifically for use in adult diagnostic health services may be more useful than those adapted 491 
from childhood measures. In addition, clinicians and researchers should examine the utility of 492 
the combined use of measures to aid the assessment, differential diagnosis of ASD, and 493 
recognition of co-occurring neurodevelopmental and mental health conditions in the context 494 
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of an overall clinical formulation. An important next step will be investigating consensus 495 
views of adults with ASD and clinicians in different clinical contexts on the most effective, 496 
efficient and acceptable combinations of diagnostic measures. Whether SQs and DMs are 497 
sensitive to clinical change in response to interventions and/or progress over time is an area 498 
for future research (Brugha et al., 2015; Bolte & Diehl, 2013), as is the impact of gender and 499 
also culture on the psychometric properties of SQs and DMs – particularly as international 500 
collaborations are increasingly used to gather data from different settings (Pinto et al., 2014).  501 
Regarding specific measures, no studies published since 2014 were found to have 502 
evaluated the ADOS modules 1-3 for adults with intellectual disability. No studies 503 
investigating the psychometric properties of the DISCO (Leekam et al., 2002; Wing et al., 504 
2002) or peer-reviewed publications evaluating the 3DI (Skuse et al., 2004; Santosh et al., 505 
2009) were identified that met the inclusion criteria for this review. Research on the clinical 506 
utility of these diagnostic measures that are used in a number of UK and European clinical 507 
settings is required.  508 
This review did not include any existing interview measures of the more subtle 509 
presentation of the broader autism phenotype (BAP) (Parr et al., 2015). Given the possibility 510 
that presentations of ASD in adulthood may be more subtle, the potential value of interviews 511 
originally designed to identify the BAP for use as ASD diagnostic tools needs to be explored.  512 
In conclusion, the findings of the current review compliment the NICE (2014) 513 
guidelines recommendations on the use of SQs and DMs in combination rather than in 514 
isolation. The current review suggests that SQs have limitations when used alone as screening 515 
measures and are unlikely to be reliable indicators of who should go on to have a full ASD 516 
diagnostic assessment. Future studies should examine the combined use of SQs alongside 517 
DMs for case recognition within the multidisciplinary diagnostic assessment in order to 518 
identify the most efficient and effective (clinical and cost) ways to ‘streamline’ diagnostic 519 
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practice and intervention planning in different settings for adults with suspected ASD. 520 
Research should also focus on which SQs and DMs both separately and in combination might 521 
be most appropriate for particular client groups – for example those with co-existing mental 522 
health conditions and those with intellectual disability.  523 
 524 
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  Table 1 ASD screening and diagnostic measures for adults and evidence recommended by NICE (NICE 2012; 2014) 
Measure Evidence  
Structured questionnaires for case recognition 
NICE (2014) recommended the use of the following SQs (with adults without intellectual disability**) as part of a multidisciplinary diagnostic assessment, but not as 
diagnostic measures in isolation. The measures are easily available and training is not required  
Autism-Spectrum Quotient (AQ-10) 
(Allison et al, 2012)  
Sensitivity/specificity (cut-off): 88%/91% (6). 
Conciseness and utility for case identification prior to a full diagnostic assessment in individuals when ASD was already 
suspected, were reported as strengths; case-control design (general population comparators) was a limitation*  
Ritvo Autism Asperger Diagnostic Scale – 
Revised (RAADS-R) 
(Ritvo et al., 2011) 
Sensitivity/ specificity (cut-off): 97%/ 100% (65).  
Evidence of reliability (test-retest, internal) and criterion validity. 
Case-control design (individuals with/without DSM-1V-TR conditions) was a limitation* 
Adult Asperger Assessment (AAA) comprises the 
Autism-Spectrum Quotient (AQ) and Empathy 
Quotient (EQ) (Baron-Cohen 2005). 
Sensitivity/ specificity (cut-off) 92% (10)  
Concerns about administration blinding to the reference standard (ASD assessment clinic)  
Asperger Syndrome Diagnostic Interview (ASDI) 
(Gillberg et al., 2001) 
Sensitivity/specificity (cut-off): 100%/ 91% (5/6 algorithm criteria)  
Some limitations in reliability and validity evidence; general population comparators 
Diagnostic measures and observational assessments 
NICE (2014) recommended the use of the following DMs for adults with & without intellectual disability; though noted that the measures must be purchased and require 
training (Lord et al 1997; 2000; Rutter et al., 2003)  
Autism Diagnostic Interview – Revised (ADI-R) 
(Lord et al., 1997) 
Sensitivity/specificity (cut-off): 91%/96% (communication 8; social reciprocity 10; restricted and repetitive behaviour 4)  
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*In studies using a case-control design participants are recruited from different populations to form the ‘cases’ and ‘controls’, which does not replicate ‘real life’ clinical 
settings and may inflate reported diagnostic accuracy (Leeflang et al, 2009; Campbell et al, 2015). 
** No case identification SQs were identified for adults with intellectual disability by NICE (2014)  
Autism Diagnostic Observation Schedule – 
Generic (ADOS-G) (superseded by ADOS-2) 
(Lord et al., 2000) 
Sensitivity/specificity (cut off): 80%/ 87% (7); 70%/ 94% (10); 90%/ 93% (13)  
Some evidence of reliability (inter-rater, test-retest, internal) and criterion validity   
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    Table 2 Search terms, study sources including databases, and study inclusion criteria 
Searches 
Search terms  (asd or asperg$ or autis$) and (screen$ or diagnos$) and (adult$ or adolescen$) 
Electronic database scoping searches Health and Social Care Information Centre (HSIC) 
Health Management Information Centre (HMIC) 
Cinahl 
Electronic database formal searches Cochrane Library 
Medline 
Embase 
PsycINFO 
Other study sources Reference lists of included articles  
Google search undertaken for the names of the measures listed in NICE (2014) 
Lead researchers in the field contacted about recently completed studies/ forthcoming publications 
Inclusion criteria 
Articles published in English  
Adult participants (where >50% of participants were over 18 years old)  
Participants had completed a structured questionnaire (SQ) or diagnostic measure (DM) as part of a comprehensive ASD diagnostic assessment  
A comprehensive ASD diagnostic assessment was considered to have taken place if the assessment was carried out by trained clinicians and incorporated 
(wherever possible) a developmental history e.g. from a family 
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To maximise the clinical/research utility of this review, evidence of sensitivity (true positives), specificity (true negatives) or receiver operating characteristics 
(ROC) analyses using a diagnostic threshold was required (Campbell et al., 2015)  
Exclusion criteria 
Studies that only evaluated measures of one of the two core ASD symptom domains, for example, the Adult Repetitive Behaviours Questionnaire-2 (Barrett et 
al 2015), as a self-report measure of restricted and repetitive behaviours; and the Empathy Quotient (EQ: Baron-Cohen & Wheelwright 2004) as a measure of 
social cognition were excluded.  
5 
 
Table 3 Summary of characteristics of SQs and DMs evaluated in the studies included in this review 
Structured questionnaires  
*Autism-Spectrum Quotient (AQ-10) 
( Allison et al, 2012)   
Abridged from the 50-item version (Baron-Cohen et al., 2001). 10 items; 5 subscales: imagination, social skills, 
communication, attention to detail, and attention switching; cut-off = 6 
*Ritvo Autism Asperger Diagnostic Scale – 
Revised (RAADS-R) (Ritvo et al., 2011) 
80-items; 4 subscales: social relatedness, circumscribed interests, sensory–motor and language  
**Social Responsiveness Scale 2 (SRS-2) 
(Constantino & Gruber, 2005) 
Standardized 65-item four-response option measure of autism traits (with five subscales) that has both self-report and 
informant versions for adults.  
**Social Communication Questionnaire (SCQ) 
(Berument et al., 1999) 
The SCQ is a 40-item screening measure of current and lifetime symptoms of ASD developed from the ADI-R 
(Lord et al., 1994; Rutter et al., 2003). It is an informant questionnaire usually completed by parents/carers.  
**Social Communication Questionnaire for Adults 
with Intellectual Disabilities (SCQ-AID) 
(Derks et al., 2017) 
The SCQ-AID was developed from the SCQ (current version) by reducing the number of items to 24 and creating a new 
algorithm.  
**Diagnostic Behavioural Assessment for ASD – 
Revised (DiBAS-R) 
(Sappok et al., 2015b) 
The DiBAS-R was developed based on DSM-5 and ICD-10 ASD criteria It is a 20-item observational screening 
assessment for adults with intellectual disability that can be administered by carers without training and is scored on a 4-
point Likert scale. 
**Autism Checklist (ACL) 
(Sipes and Matson, 2014) 
The ACL is a 10 minute observational measure that assesses the three ICD-10 core ASD domains of social interaction, 
social communication, and stereotyped and restrictive behaviours. There are four items per domain scored using ordinal 
response options of present, partly present or not present. Training is not required; however, it is intended for 
administration by clinicians with ‘ASD expertise’. 
Diagnostic measures and observational assessments 
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*Recommended in the NICE (2014) guidelines on case recognition and diagnosis of ASD in adults  
** At the time of publication of the NICE (2014) guideline no evidence on the use of the measure with adults was available that met inclusion criteria  
 
*Autism Diagnostic Interview – Revised (ADI-R) The ADI-R is a semi-structured interview conducted with parents or carers which focuses on current presentation and 
lifelong developmental history. The ADI-R focuses on social communication and interaction, plus restricted, repetitive 
and stereotyped behaviours (Lord et al 1994). 
*Autism Diagnostic Observation Schedule – 
Generic (ADOS-G) (superseded by ADOS-2) 
(Lord et al., 1999; Lord et al., 2012) 
The ADOS-2 is a standardized semi-structured diagnostic assessment. It is conducted through one-to-one 
interaction and direct observation of an individual with suspected ASD, using a range of activities and is 
delivered by a trained examiner. Ratings include non-verbal behaviours, mannerisms, restricted and repetitive 
behaviours (including repetitive speech), and aspects of social interaction (including conversational style, 
gestures and eye contact, imagination and creativity). Four modules are available for use with adults across a 
range of ability from little or no expressive language (Module 1) through to verbally fluent (Module 4). A 
revised set of algorithms has been published which comprise domains for social affect and restricted and 
repetitive behaviours. For the revised Module 4 algorithm there is a single cut-off score to differentiate ASD 
from non-ASD classifications in line with DSM-5, together with a measure of ASD symptom severity (Hus & 
Lord, 2014).  
Short observational assessments 
**Autism Mental State Examination (AMSE) 
(Grodberg et al., 2012) 
The AMSE is a brief observational tool for clinicians about the presence of ASD. There is an online training package for 
the AMSE, which comprises eight items (including pragmatics, preoccupations, interactions, repetitive behaviours and 
sensitivities).  
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Table 4 Findings from the studies evaluating Structured Questionnaires  
Study 
(country) 
Structured 
Questionnaire 
Participants 
(n): 
Recruitment 
source  
ASD 
group 
Mage 
years 
(SD) 
range  
ASD 
group % 
Males  
 Findings    
     Version  
(cut-point) 
Sensitivity Specificity AUC Reliability and validity 
Autism Spectrum Quotient (AQ)       
Booth et al 
(2013) (UK) 
AQ ASD (149): 
clinical & 
university 
disability 
service archival 
data. 
General 
population  
(134): university 
& social media.  
15-75 NR 
(mostly 
males) 
AQ 10 (6) 
AQ 50 (26) 
AQ-S (16) 
80% 
88% 
85% 
87% 
80% 
83% 
>90%  
         
 
  
Nishiyama et 
al (2014) 
(Japan) 
AQ  
 
ASD (60): 
psychiatry & 
paediatric clinics. 
General 
population 
(3147): students 
& workers. 
 
 
25.5 
(11);  
16-65 
67% AQ50 
AQ28  
AQ10 
AQ-J21 
AQ-J10 
AQ-m 
 
  
 
All 
versions 
>80% 
Though 
AQ10 & 
28 sig. 
lower**  
 
Alpha: AQ50, AQ-m & 28 
>0.84;  
AQ-J10, AQ-J21, AQ20 & 
AQ10 = 0.64-.75.  
Item level discriminant 
validity only good for 
AQ28 & AQ10. Low item 
total correlations on all 
versions of AQ. 
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Lugnegard 
Hallerback & 
Gillberg 
(2015) 
(Sweden) 
AQ  AS (51): neuro- 
developmental 
clinic. 
Schizophrenia 
(36): psychiatry 
outpatients. 
General 
population (49): 
students 
27 (4) 47%    64% 
ASD & 
SP; 89% 
ASD & 
GP 
AQ 50 scores significantly 
higher in schizophrenia 
and AS than general 
population; & higher in 
AS group (27) than 
schizophrenia (23) using 
binary scoring*; difference 
not significant on four 
point scale. 
ASD subscale scores 
significantly higher than 
GP but not significantly 
higher than schizophrenia 
except for ‘attention 
switching’** 
No gender effects except 
for ‘imagination’ (women 
lower).  
Sizoo et al 
(2015) 
(Netherlands) 
 
AQ  
 
ASD (210): 
ASD diagnostic 
clinic referrals. 
General 
population (63): 
via social media. 
 
39 
(12.5) 
18-55 
 
76% 
 
AQ 28 (80) 
AQ 10 (7)  
 
    57% 
    62% 
 
70% 
66% 
 
Both 
65% 
 
ASD group alpha = AQ 
28: 0.90; AQ 10: 0.72. 
Significantly higher scores 
for ASD than controls***  
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Ashwood et 
al (2016) 
(UK) 
AQ Suspected ASD 
(476) 
69% co-
morbidity: ASD 
diagnostic clinic 
referrals 
32 (11) 
18-70 
75% Self-report 
AQ 50 (≥26) 
AQ 50 (≥32) 
AQ 10 (≥ 6) 
 
Informant 
AQ 50 (≥26) 
AQ 50 (≥32) 
AQ 10 (≥ 6) 
        
      88% 
      71% 
      77% 
 
 
       93%    
       77%  
       79%   
   
  20% 
  35% 
  28% 
 
 
  14% 
  38% 
  31% 
 
 
Both informant and self-
report AQ 10 & 50 not 
significantly/ or only 
marginally predictive of 
ASD. 
 
No/weak correlation with  
 
ADOS-G/ ADI-R. 
GAD significantly 
predictive of AQ 10. 
Ritvo Autism Asperger Diagnostic Scale-Revised (RAADS-R)    
Sizoo et al 
(2015) 
(Netherlands) 
 
RAADS-R  
 
ASD (210): 
ASD diagnostic 
clinic referrals. 
General 
population (63): 
via social media. 
 
39 
(12.5) 
18-55 
 
76% 
 
(98) 
  
 
    73% 
 
     
58% 
 
 
67% 
 
ASD group alpha = 0.94;  
significantly higher scores 
for ASD than controls***  
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Eriksson et al 
(2013) 
(Sweden) 
RAADS-14 ASD (77); 
ADHD and 
other psychiatric 
disorders (370): 
psychiatric 
outpatients or 
online mental 
health forums; 
general 
population 
(590): 
professionals via 
mental health 
lectures.    
35 (11);  
16-58 
 
42% 
 
(≥ 14) 97% 95% (GP) 
64% (PC) 
46% (ADHD)  
 
99% 
91% 
88% 
Full scale alpha = 0.9  
Significantly higher 
total/item scores in ASD V 
controls*** 
Overlap with social 
anxiety (2 items). Females: 
significantly higher 
sensory reactivity scores 
across all groups.   
Social Responsiveness Scale (SRS)    
Nishiyama et 
al (2014) 
(Japan) 
SRS 2  ASD (60): 
psychiatry & 
paediatric clinics. 
General 
population 
(3147): students 
& workers. 
25.5 
(11);  
16-65 
67% SRS2   
 
>87% SRS-2 (65, 30 & 11 item 
versions): all versions 
alpha >0.80. Correlations 
with psychological distress 
and psychoticism.   
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Takei et al 
(2014) 
(Japan) 
SRS  ASD (65); 
psychiatric 
disorders (78): 
all psychiatry 
research 
volunteers and 
developmental 
clinic.  
General 
population 
(458): students 
& workers 
27(8) 
19-51 
 
68% 
 
65 (men)  
52 (women) 
84% 
95% 
81% (PC) 
61% (PC) 
90%  
86%  
 
Alpha = 0.96. 
Single or two factor 
structure. 
Significantly higher scores 
in ASD group than 
psychiatry group***  
No correlation with IQ. 
Convergent validity with 
ADOS (r = 0.34).  
Social Communication Questionnaire (SCQ)      
Sappok et al 
(2015a) 
(Germany) 
SCQ  ID (68); ASD & 
ID (83: 13% 
mild; 87% 
moderate/ 
severe ID): 
psychiatry clinic 
for ID. 
35 (11) 
15-76 
 
75% Current (15) 
Current (18) 
Lifetime (15) 
Lifetime (20) 
   98% 
   89% 
   92% 
   79% 
47% 
66% 
22% 
48% 
85% 
 
70% 
Current and lifetime scores 
higher in ASD + ID than 
ID**; discriminated across 
ID severity (except 
lifetime: only in mild ID).  
Sappok et al 
(2017) 
(Germany,  
UK & USA) 
SCQ 
 
ASD & ID 
(220); ID (231) 
 
All 29-
41(M) 
 
>70% 
 
Current (13)  
 
    87% 58% 80% Higher scores in 
Germany* 
Higher likelihood of 
diagnosis in UK (OR=3) 
SQs developed specifically for adults with intellectual disability     
Derks et al  
(2017) 
(Germany,  
UK & USA) 
SCQ-AID 
 
N=225 
ASD & severe 
ID:  
41% Germany; 
Across 
sites 
27-37 
(5-12) 
Across 
sites  
70-80%  
 
Reduced 
algorithm (9) 
 
    81%  62% 81% SCQ-AID higher in 
ASD/ID group than ID 
group***  
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14% USA;  
31% UK  
In/out patient 
mental health 
services. 
 93% diagnostic agreement 
on full and reduced 
algorithm 
 
Diagnostic Behavioural Assessment for ASD – Revised (DiBAS-R)     
Sappok et al 
(2014) 
(Germany) 
DiBAS-R  ID (142); ASD 
& ID (77: 18% 
mild; 82% 
moderate-
severe); ID 
mental health 
clinic 
35 (12) 69% Total (29); 
SCI (21); 
SRS (5) 
  88% 
  87% 
  94%  
   72% 
   65% 
   54% 
 89% 
 82% 
 87% 
Two factors. Alpha: SCI = 
0.91; SRS = 0.84; total = 
0.91. 
Significantly higher total 
and subscale scores ASD 
group*** 
Correlations*** with 
SCQ, PDD-MRS & ACL. 
Heinrich et al 
(2017) 
(Germany) 
 
DiBAS-R ID (289); ASD 
& ID (92; 42% 
mild/moderate; 
58% severe); ID 
psychiatric 
clinic. 
40(13) 68%     82%     67% 81% Sensitivity/specificity & 
ID level: mild/moderate 
(79%/84%); severe 
(83%/34%). 
Autism Checklist (ACL) & DiBAS-R 
Mutsaerts et 
al (2016) 
(Germany) 
Combined 
ACL and 
DiBAS-R 
84 ASD/ID: 
18% mild; 82% 
moderate/severe
. 
64 ID: ID 
psychiatric 
clinic. 
38 (12) 67% ACL 
DiBAS-R 
 
ACL+ 
DiBAS-R 
 
At least one 
measure    
  91% 
  75% 
 
  70% 
 
    
   95% 
   75% 
   75%  
 
    88% 
 
     
     63% 
85% 
81% 
                     
Significantly higher scores 
on DiBAS-R and ACL in 
ASD than ID*** 
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NR: not reported; AUC: area under curve; AS: Asperger Syndrome; GAD: generalised anxiety disorder; GP: general population; PC: psychiatric controls; 
SP: schizophrenia.  ID: intellectual disability; SCI: Social Communication and Interaction; ADHD: attention deficit hyperactivity disorder; SRS: 
Stereotypy, Rigidity, and Sensory Abnormalities; AQ-J: Japanese version; AQ-m: modified response option of 1-4; PDD-MRS: Pervasive Developmental 
Disorder in Mental Retardation Scale; *P<0.05;** P<0.01; ***P<0.001.   
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Table 3 Table 5 Findings from studies evaluating diagnostic measures and observational assessments 
 
Study 
(country) 
Measure Participants (n) 
Recruitment  
source 
ASD 
Mage: 
years 
(SD)  
range  
ASD 
Male  
  Findings   
Diagnostic 
measures 
    Version 
(cut-point) 
Sensitivity Specificity AUC  
Autism Diagnostic Interview-Revised (ADI-R)  
Fusar-Poli et al 
(2017) 
(Italy) 
ADI-R ASD (78); other 
psychiatric 
diagnoses (35). 
ASD diagnosis 
clinic consecutive 
referrals. 
 
 
 
 
 
26(9) 
18-55 
73% ADI-R 
CL (8) 
SI (10) 
RRB (3) 
 
ADI-R & 
ADOS-G 
  43% 
  69% 
  71% 
  86% 
 
 42% 
   95% 
   79% 
   79% 
   37% 
 
 100% 
 69% Discriminant validity**  
Autism Diagnostic Observation Schedule (second edition) (ADOS-2) Module 4 revised algorithm  
Hus & Lord 
(2014) (USA) 
ADOS 2 
Module 4  
 
ASD (347); 
psychiatric (90): 
all research 
participants & 
ASD clinic 
referrals  
21 (7)  
9-55   
80%  (8) >80% >80%  Calibrated severity score 
(CSS) independent of 
participant characteristics. 
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De Bildt et al 
(2016) 
(Netherlands) 
 
ADOS 
Module 4  
ASD (38); 
schizophrenia (18); 
psychopathy (16);  
non-clinical 
controls (21): all 
previous research 
participants 
32 (11)  
18-66 
100% 
  
  (8) 
 (10) 
61% 
53% 
SP 50% 
SP 22% 
PP 100% 
GP >95% 
66% ASD & SP. 
75% ASD & SP 
& PP. 
86% ASD & PP 
88% ASD & GP 
Mean total and subscale 
scores significantly higher 
for ASD than psychopathy 
& controls***; not 
compared to schizophrenia.  
 
Pugliese et al 
(2015) (USA) 
ADOS  
Module 4  
ASD (253); non-
ASD (68: 43 
having psychiatric 
diagnosis): all 
research 
participants & 
ASD clinic 
referrals 
19 (7)  
11–61 
77%   85% 72%  Significantly higher scores 
in ASD on all except 7 
items. Majority of SA & 
RRB inter-item correlations 
significant. 
Sensitivity/ specificity 
slightly higher >16 years, 
VIQ <85 or >115. Cross 
gender sensitivity >80%; 
specificity lower for males 
(65 %) than females (86 %).  
CSS correlated with SRS*, 
negatively with SCQ*. No 
significant correlation with 
ADI or adaptive behaviour. 
Langmann et 
al., (2017)  
ADOS  
Module 4 
ASD (165); 
Non ASD/other 
diagnosis (191) 
21(7) 
13-54 
82% Original 
(7) 
(10) 
Revised 
(8) 
(10) 
 
82% 
57% 
 
86% 
75% 
 
83% 
92% 
 
80% 
86% 
 Best discrimination: <18 
years; lower and average 
IQ. 
Sensitivity females cut-off 
10: 35% (original); 59% 
(revised).     
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RRB: Restricted and Repetitive Behaviour; CL: communication & language; SI: social interaction; Comm: communication; RSI: reciprocal social 
interaction; SA: social affect; SP: schizophrenia; PP: psychopathy; GP: general population: VIQ: verbal IQ; *P<0.05, ** P<0.01, *** P<0.001   
Fusar-Poli et 
al 
(2017) 
(Italy) 
ADOS 2 
Module 4 
ASD (78); other 
psychiatric 
diagnoses (35). 
ASD diagnosis 
clinic consecutive 
referrals. 
26(9) 
18-55 
73%    Original 
   Comm. 
   RSI 
   Revised 
 
ADOS 2 & 
ADI-R 
 
86% 
90% 
96% 
87% 
 
42% 
82% 
63% 
63% 
74% 
 
100% 
84% 
 
 
81% 
Discriminant validity*** 
Maddox et al 
(2017) 
(USA) 
ADOS 2 
Module 4 
ASD (6); 
Psychosis (57); 
Mood disorder/ 
other (12) 
Outpatient 
psychiatry service. 
31(14) 67% Original 
Revised          
100% 
100% 
74% 
70% 
 Both ASD true positives & 
ASD false positives 
(psychosis) mean score on 
social communication 
domain = 10.5. 
 
Observational tools to aid clinical judgement        
Autism Mental State Examination (AMSE)   
Grodberg et al 
(2014) (USA) 
AMSE  
 
 
ASD (23); 
psychiatric 
diagnosis (27): all 
ASD assessment 
clinic consecutive 
self-referrals 
18-45 
 
 
NR 
 
 
DSM-5 
reference 
ADOS 
reference 
(≥ 5) 
 91% 
 
 84%       
  93% 
 
  92% 
     97% 
 
 
      89% 
 
Optimal cut score for those 
with DSM-5 or ADOS 
diagnosis=5. 
Floor effect on language 
and pointing items. 
